No abstract available
Publication types
-
Consensus Development Conference
-
Guideline
-
Practice Guideline
-
Review
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / drug therapy
-
Diagnosis, Differential
-
Disease Susceptibility
-
Female
-
Global Health
-
HIV Infections / complications
-
Humans
-
Immunosuppressive Agents / adverse effects*
-
Immunosuppressive Agents / therapeutic use
-
Incidence
-
Inflammatory Bowel Diseases / complications
-
Inflammatory Bowel Diseases / diagnosis
-
Inflammatory Bowel Diseases / drug therapy*
-
Infliximab
-
Male
-
Middle Aged
-
Opportunistic Infections / etiology
-
Opportunistic Infections / prevention & control
-
Prevalence
-
Radiography
-
Severity of Illness Index
-
Spain / epidemiology
-
Tuberculin Test
-
Tuberculosis / epidemiology
-
Tuberculosis / etiology*
-
Tuberculosis / prevention & control
-
Tuberculosis, Gastrointestinal / diagnosis
-
Tuberculosis, Pulmonary / diagnostic imaging
Substances
-
Antibodies, Monoclonal
-
Immunosuppressive Agents
-
Infliximab